Literature DB >> 9885468

The measurement of indirect costs in the health economics evaluation literature. A review.

P Jacobs1, K Fassbender.   

Abstract

In this paper we develop a framework to categorize the concepts used to estimate indirect costs in economic evaluation. We apply this framework in a literature review of economic evaluation studies. We searched all English language literature from 1994-96. Following the application of a search algorithm, which yielded 25 articles, we abstracted information from these articles to determine the methods used to identify the relative contribution of indirect costs of the cost-effectiveness ratio, the time horizon selected by the authors, the identification of those activities that were foregone, the time given up by these activities, and the valuation placed on this time. These methods were then assessed. Indirect costs, as they have been measured, significantly influence efficiency ratios. A wide variation exists among studies in how they incorporate each of the components of indirect costs. All of the four components that were identified will affect the measurement of indirect cost. Future guidelines in this area should address the entire measurement process.

Mesh:

Year:  1998        PMID: 9885468     DOI: 10.1017/s0266462300012095

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  15 in total

1.  The economic gains of achieving reduced alcohol consumption targets for Australia.

Authors:  Anne Magnus; Dominique Cadilhac; Lauren Sheppard; Toby Cumming; Dora Pearce; Rob Carter
Journal:  Am J Public Health       Date:  2012-05-17       Impact factor: 9.308

2.  Methodological reviews of economic evaluations in health care: what do they target?

Authors:  Maria-Florencia Hutter; Roberto Rodríguez-Ibeas; Fernando Antonanzas
Journal:  Eur J Health Econ       Date:  2013-08-24

Review 3.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  A Systematic Review of the Economic and Humanistic Burden of Gout.

Authors:  Gemma E Shields; Stephen M Beard
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

Review 5.  Valuing patient and caregiver time: a review of the literature.

Authors:  Jennifer E Tranmer; Denise N Guerriere; Wendy J Ungar; Peter C Coyte
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

6.  The Alberta population-based prospective evaluation of the quality of life outcomes and economic impact of bariatric surgery (APPLES) study: background, design and rationale.

Authors:  Raj S Padwal; Sumit R Majumdar; Scott Klarenbach; Dan W Birch; Shahzeer Karmali; Linda McCargar; Konrad Fassbender; Arya M Sharma
Journal:  BMC Health Serv Res       Date:  2010-10-08       Impact factor: 2.655

7.  Cost-effectiveness of pharmacotherapy to reduce obesity.

Authors:  J Lennert Veerman; Jan J Barendregt; Megan Forster; Theo Vos
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  Measuring resource utilization in patient-oriented comparative effectiveness research: a psychometric study of the Resource Utilization Questionnaire.

Authors:  Arlene Smaldone; Argerie Tsimicalis; Patricia W Stone
Journal:  Res Theory Nurs Pract       Date:  2011       Impact factor: 0.745

9.  Assessment of viral genotype impact to the cost-effectiveness and overall costs of care for PEG-interferon-2α + ribavirine treated chronic hepatitis C patients.

Authors:  Mihajlo Jakovljevic; Zeljko Mijailovic; Biljana Popovska Jovicic; Predrag Canovic; Olgica Gajovic; Mirjana Jovanovic; Dejan Petrovic; Olivera Milovanovic; Natasa Djordjevic
Journal:  Hepat Mon       Date:  2013-06-19       Impact factor: 0.660

10.  Economic consequences incurred by living kidney donors: a Canadian multi-center prospective study.

Authors:  S Klarenbach; J S Gill; G Knoll; T Caulfield; N Boudville; G V R Prasad; M Karpinski; L Storsley; D Treleaven; J Arnold; M Cuerden; P Jacobs; A X Garg
Journal:  Am J Transplant       Date:  2014-03-05       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.